- +77.8% price growth over the last year
- Bullish trend confirmed on both short and long timeframes
- Trading above its 200-day moving average
Green day on Monday for ProShares Ultra Nasdaq Biotechnology
(Updated on Jun 15, 2026)
The ProShares Ultra Nasdaq Biotechnology ETF price gained 1.29% on the last trading day (Monday, 15th Jun 2026), rising from $82.65 to $83.72. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the ETF fluctuated 1.90% from a day low at $83.19 to a day high of $84.77. The price has risen in 6 of the last 10 days and is up by 2.77% over the past 2 weeks. Volume fell on the last day by -711 shares and in total, 5 thousand shares were bought and sold for approximately $394.05 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The ETF lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the ETF is expected to rise 2.57% during the next 3 months and, with a 90% probability hold a price between $78.99 and $93.23 at the end of this 3-month period.
BIB Signals & Forecast
The ProShares Ultra Nasdaq Biotechnology ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF, but the ETF has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $80.96 and $81.76. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 9.16%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for ProShares Ultra Nasdaq Biotechnology ETF
ProShares Ultra Nasdaq Biotechnology finds support from accumulated volume at $82.90 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This ETF has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the ETF moved $1.58 between high and low, or 1.90%. For the last week the ETF has had daily average volatility of 3.96%.
Our recommended stop-loss: $80.82 (-3.46%) (This ETF has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 9 days ago.)
Trading Expectations (BIB) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect ProShares Ultra Nasdaq Biotechnology to open at $83.89, and during the day (based on 14 day Average True Range), to move between $82.26 and $85.18, which gives a possible trading interval of +/-$2.92 (+/-3.55%) up or down from last closing price. If ProShares Ultra Nasdaq Biotechnology takes out the full calculated possible swing range there will be an estimated 3.55% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $82.90 (0.97%) than the resistance at $84.58 (1.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is ProShares Ultra Nasdaq Biotechnology ETF A Buy?
ProShares Ultra Nasdaq Biotechnology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.795
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 16, 2026 - $83.89 ( 0.211%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BIB Performance
Trading levels for BIB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 85.47 | 2.10% |
| R2 | 84.87 | 1.38% |
| R1 | 84.50 | 0.93% |
| Price | 83.72 | |
| S1 | 83.29 | -0.510% |
| S2 | 82.92 | -0.96% |
| S3 | 82.31 | -1.68% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 87.64 | 4.68% |
| R2 | 87.03 | 3.96% |
| R1 | 84.58 | 1.04% |
| Price | 83.72 | |
| S1 | 82.90 | -0.97% |
| S2 | 82.71 | -1.21% |
| S3 | 75.95 | -9.28% |
BIB Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 25, 2026 | Mar 25, 2026 | Mar 31, 2026 | $0.0071 | 0.0091% |
| 2 | Dec 23, 2025 | Dec 24, 2025 | Dec 31, 2025 | $0.135 | 0.163% |
| 3 | Sep 23, 2025 | Sep 24, 2025 | Sep 30, 2025 | $0.181 | 0.326% |
| 4 | Jun 24, 2025 | Jun 25, 2025 | Jul 01, 2025 | $0.171 | 0.368% |
| 5 | Mar 25, 2025 | Mar 26, 2025 | Apr 01, 2025 | $0.131 | 0.287% |
FAQ
Click here for our free guide on how to buy ProShares Ultra Nasdaq Biotechnology ETF.
Buy BIB